Scatter factor/hepatocyte growth factor (SF/HGF) content and function in human gliomas

International Journal of Developmental Neuroscience

Volumn 17, Issue 5-6, 1999, Pages 517-530

  Lamszus, Katrin ^a   Laterra, John ^b   Westphal, Manfred ^a   Rosen, Eliot M ^c  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL MODEL; CELL LINE; CELL MOTILITY; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE TRANSFER; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW;

EID: 0032844762     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-5748(99)00008-8     Document Type: Article

References (58)

1. Bladt F., Riethmacher D., Isenmann S., Aguzzi A., Birchmeier C. Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature. 376:1995;768-771.
2. Bottaro D.P., Rubin J.S., Faletto D.L., Chan A.M.L., Kmiecik T.E., Vande Woude G.F., Aaronson S.A. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science (Washington DC). 251:1991;802-804.
3. Bussolino F., Di Renzo M.F., Ziche M., Bocchietto E., Olivero M., Naldini L., Gaudino G., Tamagnone L., Coffer A., Comoglio P.M. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J. Cell. Biol. 119:1992;629-641.
4. Di Renzo M.F., Bertolotto A., Olivero M., Crepaldi T., Pagni C.A., Comoglio P.M. Selective expression of the met/HGF-receptor in human central nervous system microglia. Oncogene. 8:1993;219-222.
5. Furie M.B., Cramer E.B., Naprstek B.L., Silverstein S.C. Cultured endothelial cell monolayers that restrict the transendothelial passage of macromolecules and electrical current. J. Cell Biol. 98:1984;1033-1041.
6. Gherardi E., Gray J., Stoker M., Perryman M., Furlong R. Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movement. Proc. Natl. Acad. Sci. U.S.A. 86:1989;5844-5848.
7. Ghoussoub R.A.D., Dillon D.A., D'Aquila T., Rimm E.B., Fearon E.R., Rimm D.L. Expression of c-met is a strong independent prognostic factor in breast carcinoma. Cancer. 82:1998;1513-1520.
8. Gospodarowicz D., Cheng J., Lui G.M., Baird A., Böhlen P. Isolation of brain fibroblast growth factor by heparin-Sepharose affinity chromatography: identity with pituitary fibroblast growth factor. Proc. Natl. Acad. Sci. U.S.A. 81:1984;6963-6967.
9. Grant D.S., Kleinman H.K., Goldberg I.D., Bhargava M.M., Nickoloff B.J., Kinsella J.L., Polverini P., Rosen E.M. Scatter factor induces blood vessel formation in vivo. Proc. Natl. Acad. Sci. U.S.A. 90:1993;1937-1941.
10. Hirose Y., Kojima M., Sagoh M., Murakami H., Yoshida K., Shimazaki K., Kawase T. Immunohistochemical examination of c-Met protein expression in astrocytic tumors. Acta Neuropathol. 95:1998;345-351.
11. Jeffers M., Rong S., Vande-Woude G.F. Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network. Mol. Cell. Biol. 16:1996;1115-1125.
12. Jin L., Fuchs A., Schnitt S.S., Yao Y., Joseph A., Lamszus K., Goldberg I.D., Rosen E.M. Expression of scatter factor and c-met receptor in benign and malignant breast tissue. Cancer. 79:1997;749-760.
13. Jung W., Castren E., Odenthal M., Vande Woude G.F., Ishii T., Dienes H.P., Lindholm D., Schirmacher P. Expression and functional interaction of hepatocyte growth factor-scatter factor and its receptor c-met in mammalian brain. J. Cell. Biol. 126:1994;485-494.
14. Kanda H., Tajima H., Lee G.H., Nomura K., Ohtake K., Matsumoto K., Nakamura T., Kitagawa T. Hepatocyte growth factor transforms immortalized mouse liver epithelial cells. Onocgene. 8:1993;3047-3053.
15. Koochekpour S., Jeffers M., Rulong S., Taylor G., Klineberg E., Hudson E.A., Resau J.H., Vande Woude G.F. Met and hepatocyte growth factor expression in human gliomas. Cancer Res. 57:1997;5391-5398.
16. Lamszus K., Joseph A., Jin L., Yao Y., Chowdhury S., Fuchs A., Goldberg I.D., Rosen E.M. Scatter factor binds to thrombospondin and other extracellular matrix components. Am. J. Pathol. 149:1996;805-819.
17. Lamszus K., Jin L., Fuchs A., Shi E., Chowdhury S., Yao Y., Polverini P.J., Laterra J., Goldberg I.D., Rosen E.M. Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice. Lab. Invest. 76:1997;339-353.
18. Lamszus K., Schmidt N.O., Jin L., Laterra J., Zagzag D., Way D., Witte M., Weinand M., Goldberg I.D., Westphal M., Rosen E.M. Scatter factor promotes motility of human glioma and neuromicrovascular endothelial cells. Int. J. Cancer. 75:1998;19-28.
19. Lamszus, K., Schmidt, N. O., Ergün, S., Westphal, M., Isolation and culture of human neuromicrovascular endothelial cells for the study of angiogenesis in vitro. J. Neurosci. Res., 1999, 55, 370-381.
20. Laterra J., Nam M., Rosen E.M., Rao J.S., Lamszus K., Goldberg I.D., Johnston P. Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo. Lab. Invest. 76:1997;565-577.
21. Laterra J., Rosen E., Nam M., Ranganathan S., Fielding K., Johnston P. Scatter factor/hepatocyte growth factor expression enhances human glioblastoma tumorigenicity and growth. Biochem. Biophys. Res. Commun. 235:1997;743-747.
22. Liu M.L., Mars W.M., Michalopoulos G.K. Hepatocyte growth factor inhibits cell proliferation in vivo of rat hepatocellular carcinomas induced by diethylnitrosamine. Carcinogenesis. 16:1995;841-843.
23. Montesano R., Orci L. Tumor-promoting phorbol esters induce angiogenesis in vitro. Cell. 42:1985;469-477.
24. Moriyama T., Kataoka H., Tsubouchi H., Koono M. Concomitant expression of hepatocyte growth factor (HGF), HGF activator and c-met genes in human glioma cells in vitro. FEBS Lett. 372:1995;78-82.
25. Moriyama T., Kataoka H., Seguchi K., Tsubouchi H., Koono M. Effects of hepatocyte growth factor (HGF) on human glioma cells in vitro: HGF acts as a motility factor in glioma cells. Int. J. Cancer. 66:1996;678-685.
26. Moriyama T., Kataoka H., Hamasuna R., Yokogami K., Uehara H., Kawano H., Goya T., Tsubouchi H., Koono M., Wakisaka S. Up-regulation of vascular endothelial growth factor induced by hepatocyte growth factor/scatter factor stimulation in human glioma cells. Biochem. Biophys. Res. Commun. 249:1998;73-77.
27. Mueller H.W., Michel A., Heckel D., Fischer U., Tönnes M., Tsui L.C., Scherer S., Zang K.D., Meese E. Identification of an amplified gene cluster in glioma including two novel amplified genes isolated by exon trapping. Human Genet. 101:1997;190-197.
28. Nakamura T., Nawa K., Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem. Biophys. Res. Commun. 122:1984;1450-1459.
29. Nakamura T., Teramoto H., Ichihara A. Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. Proc. Natl. Acad. Sci. U.S.A. 83:1986;6489-6493.
30. Plate K.H., Risau W. Angiogenesis in malignant gliomas. Glia. 15:1995;339-347.
31. Rahimi N., Saulnier R., Nakamura T., Park M., Elliott B. Role of hepatocyte growth factor in breast cancer: a novel mitogenic factor secreted by adipocytes. DNA Cell Biol. 13:1994;1189-1197.
32. Reifenberger J., Reifenberger G., Liu L., James C.D., Wechsler W., Collins V.P. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am. J. Pathol. 145:1994;1175-1190.
33. Rong S., Segal S., Anver M., Resau J.H., Vande-Woude G.F. Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation. Proc. Natl. Acad. Sci. U.S.A. 91:1994;4731-4735.
34. Rosen E.M., Knesel J., Goldberg I.D., Jin L., Bhargava M., Joseph A., Zitnik R., Wines J., Kelley M., Rockwell S. Scatter factor modulates the metastatic phenotype of the EMT6 mouse mammary tumor. Int. J. Cancer. 57:1994;706-714.
35. Rosen E.M., Nigam S.K., Goldberg I.D. Scatter factor and the c-met receptor: a paradigm for mesenchymal/epithelial interaction. J. Cell. Biol. 127:1994;1783-1787.
36. Rosen E.M., Laterra J., Joseph A., Jin L., Fuchs A., Way D., Witte M., Weinand M., Goldberg I.D. Scatter factor expression and regulation in human glial tumors. Int. J. Cancer. 67:1996;248-255.
37. Rosen E.M., Lamszus K., Laterra J., Polverini P.J., Rubin J.S., Goldberg I.D. HGF/SF in angiogenesis. Ciba Found Symp. 212:1997;215-226.
38. Samoto K., Ikezaki K., Ono M., Shono T., Kohno K., Kuwano M., Fukui M. Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. Cancer Res. 55:1995;1189-1193.
39. Schmidt C., Bladt F., Goedecke S., Brainkmann V., Zschiesche W., Sharpe M., Gherardi E., Birchmeier C. Scatter factor/hepatocyte growth factor is essential for liver development. Nature. 373:1995;699-702.
40. Schmidt L., Duh F.M., Chen F., Kishida T., Glenn G., Choyke P., Scherer S.W., Zhuang Z., Lubensky I., Dean M., Allikmets R., Chidambaram A., Bergerheim U.R., Feltis J.T., Casadevall C., Zamarron A., Bernues M., Richard S., Lips C.J.M., Walther M.M., Tsui L.C., Geil L., Orcutt M.L., Stackhouse T., Lipan J., Slife L., Brauch H., Decker J., Niehans G., Hughson M.D., Moch H., Storkel S., Lerman M.I., Linehan W.M., Zbar B. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nature Gen. 16:1997;68-73.
41. Schmidt, N. O., Westphal, M., Hagel, C., Ergün, S., Stavrou, D., Rosen, E. M., Lamszus, K., Levels of Vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis. Int. J. Cancer, 1998, 84, 10-18.
42. Shiota G., Rhoads D.B., Wang T.C., Nakamura T., Schmidt E.V. Hepatocyte growth factor inhibits growth of hepatocellular carcinoma cells. Proc. Natl. Acad. Sci. U.S.A. 89:1992;373-377.
43. Soriano J.V., Pepper M.S., Nakamura T., Orci L., Montesano R. Hepatocyte growth factor stimulates extensive development of branching duct-like structures by cloned mammary gland epithelial cells. J. Cell Sci. 108:1995;413-430.
44. Stoker M., Gherardi E., Perryman M., Gray J. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature. 327:1987;239-242.
45. Takahashi J.A., Fukumoto M., Igarashi K., Oda Y., Kikuchi H., Hatanaka M. Correlation of basic fibroblast growth factor expression levels with the degree of malignancy and vascularity in human gliomas. J. Neurosurg. 76:1992;792-798.
46. Takayama H., LaRochelle W.J., Anver M., Bockman D., Merlino G. Scatter factor/hepatocyte growth factor as a regulator of skeletal muscle and neural crest development. Proc. Natl. Acad. Sci. U.S.A. 93:1996;5866-5871.
47. Toi M., Taniguchi T., Ueno T., Asano M., Funata N., Sekiguchi K., Iwanari H., Tominaga T. Significance of circulating hepatocyte growth factor level as a prognostic indicator in primary breast cancer. Clin. Cancer Res. 4:1998;659-664.
48. Tuck A.B., Park M., Sterns E.E., Boag A., Elliott B.E. Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma. Am. J. Pathol. 148:1996;225-232.
49. Ueki T., Fujimoto J., Suzuki T., Yamamoto H., Okamoto E. Expression of hepatocyte growth factor and its receptor, the c-met proto-oncogene, in hepatocellular carcinoma. Hepatology. 25:1997;619-623.
50. Van Belle E., Witzenbichler B., Chen D., Silver M., Chang L., Schwall R., Isner J.M. Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor. Circulation. 97:1998;381-390.
51. Wang Y., Selden C., Morgan N., Stamp G.W.H., Hodgson H.J.F. Hepatocyte growth factor/scatter factor expression in human mammary epithelium. Am. J. Pathol. 144:1994;675-682.
52. Weidner K.M., Arakaki N., Hartmann G., Vandekerckhove J., Weingart S., Rieder H., Fonatsch C., Tsubouchi H., Hishida T., Daikuhara Y., Birchmeier W. Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc. Natl. Acad. Sci. U.S.A. 88:1991;7001-7005.
53. Westphal M., Herrmann H.D. Growth factor biology and oncogene activation in human gliomas and their implications for specific therapeutic concepts. Neurosurgery. 25:1989;681-694.
54. Westphal M., Hänsel M., Hamel W., Kunzmann R., Hölzel F. Karyotype analysis of 20 human glioma cell lines. Acta Neurochir. Wien. 126:1994;17-26.
55. Yamada T., Yoshiyama Y., Tsuboi Y., Shimomura T. Astroglial expression of hepatocyte growth factor and hepatocyte growth factor activator in human brain tissues. Brain Res. 762:1997;251-255.
56. Yamashita J., Ogawa M., Yamashita S., Nomura K., Kuramoto M., Saishoji T., Shin S. Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer. Cancer Res. 54:1994;1630-1633.
57. Yao Y., Jin L., Fuchs A., Joseph A., Hastings H.M., Goldberg I.D., Rosen E.M. Scatter factor protein levels in human breast cancers. Am. J. Pathol. 149:1996;1707-1717.
58. Zagzag D., Miller D.C., Sato Y., Rifkin D.B., Burstein D.E. Immunohistochemical localization of basic fibroblast growth factor in astrocytomas. Cancer Res. 50:1990;7393-7398.